Pages that link to "Q35746266"
Jump to navigation
Jump to search
The following pages link to Liver biopsy sampling in chronic viral hepatitis (Q35746266):
Displaying 50 items.
- Chronic hepatitis C and liver fibrosis. (Q26825671) (← links)
- Is liver biopsy still needed in children with chronic viral hepatitis? (Q30398796) (← links)
- Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agents (Q30439873) (← links)
- ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study (Q30454106) (← links)
- Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings (Q30454108) (← links)
- Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B. (Q33638467) (← links)
- Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B (Q33787916) (← links)
- Correlation of Laparoscopic Liver Biopsy to Elasticity Measurements (FibroScan) in Patients With Chronic Liver Disease (Q34978447) (← links)
- HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication (Q34998266) (← links)
- Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease (Q35200808) (← links)
- Influence of expert-dependent variability over the performance of noninvasive fibrosis assessment in patients with chronic hepatitis C by means of texture analysis (Q35645808) (← links)
- Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C. (Q35770548) (← links)
- Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures (Q35819904) (← links)
- Noninvasive diagnosis of fibrosis in chronic liver disease (Q35878301) (← links)
- Gastritis staging in clinical practice: the OLGA staging system (Q35929516) (← links)
- Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease (Q36014015) (← links)
- Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit (Q36159244) (← links)
- Liver fibrosis: Review of current imaging and MRI quantification techniques. (Q36226373) (← links)
- Non-invasive evaluation of hepatic fibrosis: don't count your chickens before they're hatched (Q36394872) (← links)
- Computer-aided morphometry of liver inflammation in needle biopsies (Q36474501) (← links)
- Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. (Q37126762) (← links)
- Why, who and how should perform liver biopsy in chronic liver diseases. (Q37182969) (← links)
- Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. (Q37192623) (← links)
- Liver biopsies for chronic hepatitis C: should nonultrasound-guided biopsies be abandoned? (Q37291699) (← links)
- Chronic viral hepatitis: the histology report. (Q37860676) (← links)
- Gastritis: the histology report (Q37860681) (← links)
- Evaluation of histological staging systems for primary biliary cirrhosis: correlation with clinical and biochemical factors and significance of pathological parameters in prognostication (Q38183450) (← links)
- Role of aetiology in the progression, regression, and parenchymal remodelling of liver disease: implications for liver biopsy interpretation. (Q38751392) (← links)
- Should surveillance for liver cancer be modified in hepatitis C patients after treatment-related cirrhosis regression? (Q38758591) (← links)
- Relationship between the liver tissue shear modulus and histopathologic findings analyzed by intraoperative shear wave elastography and digital microscopically assisted morphometry in patients with hepatocellular carcinoma (Q40160315) (← links)
- New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment (Q40393947) (← links)
- Angiopoietin-2/angiopoietin-1 as non-invasive biomarker of cirrhosis in chronic hepatitis C. (Q40428093) (← links)
- The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B. (Q40437910) (← links)
- Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection (Q40552850) (← links)
- Development of algorithms based on serum markers and transient elastography for detecting significant fibrosis and cirrhosis in chronic hepatitis B patients: Significant reduction in liver biopsy (Q40758150) (← links)
- Checkmate to liver biopsy in chronic hepatitis C? (Q41678369) (← links)
- Transjugular liver biopsy: results of 97 patients (Q41894847) (← links)
- Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration (Q42272013) (← links)
- Liver fibrosis: natural history may be affected by the biopsy sample (Q43004697) (← links)
- How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C? (Q43046834) (← links)
- The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases (Q44595693) (← links)
- Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital (Q44812133) (← links)
- Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels (Q45420734) (← links)
- Influence of dietary macronutrients on liver fat accumulation and metabolism. (Q47744258) (← links)
- Adequacy of percutaneous non-targeted liver biopsy under real-time ultrasound guidance when comparing the Biopince™ and Achieve™ biopsy needle (Q47875192) (← links)
- Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. (Q51509141) (← links)
- SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. (Q51848337) (← links)
- Evaluation of liver fibrosis with a monoexponential model of intravoxel incoherent motion magnetic resonance imaging. (Q55155378) (← links)
- Diagnostic Performance of Real-Time Elastography in the Assessment of Advanced Fibrosis in Chronic Hepatitis C. (Q55497268) (← links)
- Liver biopsy (Q57782748) (← links)